Tumor‐Bearing Status Accelerates Bleomycin‐Induced Pulmonary Inflammation via Endothelial Activation
Thoracic Cancer · 2026-04 · 17 (7)
DOI: 10.1111/1759-7714.70272 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thoracic Cancer, online erschienen am 30.03.2026. Verfasst von Shoko Isoyama und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan. Hauptthemen laut MEDLINE: Bleomycin, Pneumonia, Carcinoma, Lewis Lung. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Background
Drug‐induced lung disease (DILD) is a severe adverse event of cancer treatment. Several clinical reports have demonstrated an association between DILD and tumor progression. However, the underlying mechanism remains unclear. This study aimed to elucidate the role of tumor‐bearing status in the development of DILD.
Methods
We prepared a subcutaneous Lewis lung carcinoma (LLC) and KLN205‐bearing model. To trigger DILD, bleomycin (BLM) was administered subcutaneously. mRNA expression associated with endothelial activation (PAI‐1, vWF, and ICAM‐1), inflammatory cell infiltration, and alveolar wall thickness was assessed by using bronchioalveolar lavage fluid (BALF) and lung tissue. Additionally, the role of high‐mobility group box 1 (HMGB1) in tumor‐bearing status was examined.
Results
Compared with control mice, LLC‐ and KLN205‐bearing mice showed a tendency toward increased expression of at least one of PAI‐1, vWF, and ICAM‐1 on endothelium, along with inflammatory cell infiltration in the lungs. BLM‐treated mice with LLC showed more inflammatory cell infiltration than BLM‐treated mice, accompanied by a significant increase in PAI‐1, vWF, and ICAM‐1 expression on endothelium. Moreover, BLM‐treated mice with LLC exhibited pronounced alveolar wall thickening. In LLC‐bearing mice, serum HMGB1 levels were significantly higher compared with control mice. Additionally, inflammatory cell infiltration in the lungs tended to be increased by the intraperitoneal injection of HMGB1, which was accompanied by increased expression of vWF and ICAM‐1 on endothelium.
Conclusions
This study showed that tumor‐bearing status elicits proinflammatory activation in endothelial cells and inflammatory cell infiltration into the lungs that aggravates DILD caused by BLM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.
- Department of Respiratory Medicine, Hiroshima University Hospital, Hiroshima, Japan.
- Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.
- Department of Physical Analysis and Therapeutic Sciences, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.
ORCID-Profile: Kakuhiro Yamaguchi, Hironobu Hamada, Noboru Hattori
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Isoyama, S., Yamaguchi, K., Iwamoto, H., Horimasu, Y., Funaishi, K., Shimoji, K., Sakamoto, S., Masuda, T., Nakashima, T., Ohshimo, S., Hamada, H., & Hattori, N. (2026). Tumor‐Bearing Status Accelerates Bleomycin‐Induced Pulmonary Inflammation via Endothelial Activation. Thoracic Cancer, 17(7). https://doi.org/10.1111/1759-7714.70272
Vancouver
Isoyama S, Yamaguchi K, Iwamoto H, Horimasu Y, Funaishi K, Shimoji K, et al. Tumor‐Bearing Status Accelerates Bleomycin‐Induced Pulmonary Inflammation via Endothelial Activation. Thoracic Cancer. 2026;17(7). doi:10.1111/1759-7714.70272
BibTeX
@article{Isoyama2026,
author = {Isoyama, Shoko and Yamaguchi, Kakuhiro and Iwamoto, Hiroshi and Horimasu, Yasushi and Funaishi, Kunihiko and Shimoji, Kiyofumi and Sakamoto, Shinjiro and Masuda, Takeshi and Nakashima, Taku and Ohshimo, Shinichiro and Hamada, Hironobu and Hattori, Noboru},
title = {Tumor‐Bearing Status Accelerates Bleomycin‐Induced Pulmonary Inflammation via Endothelial Activation},
journal = {Thoracic Cancer},
year = {2026},
volume = {17},
number = {7},
doi = {10.1111/1759-7714.70272}
}
EUVIMED